Targeting Platelet-Derived Growth Factor Receptor β+ Scaffold Formation Inhibits Choroidal Neovascularization

American Journal of Pathology

Volumn 186, Issue 7, 2016, Pages 1890-1899

  Strittmatter, Karin ^a   Pomeroy, Hayley ^a   Marneros, Alexander G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SCAFFOLD PROTEIN;

AGE RELATED MACULAR DEGENERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBRETINAL NEOVASCULARIZATION; THERAPY EFFECT; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DISEASE MODEL; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PERICYTES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA;

EID: 84997525162     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2016.02.018     Document Type: Article

References (15)

1. 1 CATT Research Group, Martin, D.F., Maguire, M.G., Ying, G.S., Grunwald, J.E., Fine, S.L., Jaffe, G.J., Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364 (2011), 1897–1908.
2. 2 Martin, D.F., Maguire, M.G., Fine, S.L., Ying, G.S., Jaffe, G.J., Grunwald, J.E., Toth, C., Redford, M., Ferris, F.L. 3rd, Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 119 (2012), 1388–1398.
3. 3 Rofagha, S., Bhisitkul, R.B., Boyer, D.S., Sadda, S.R., Zhang, K., Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology 120 (2013), 2292–2299.
4. 4 He, L., Marneros, A.G., Macrophages are essential for the early wound healing response and the formation of a fibrovascular scar. Am J Pathol 182 (2013), 2407–2417.
5. 5 Cooke, V.G., LeBleu, V.S., Keskin, D., Khan, Z., O'Connell, J.T., Teng, Y., Duncan, M.B., Xie, L., Maeda, G., Vong, S., Sugimoto, H., Rocha, R.M., Damascena, A., Brentani, R.R., Kalluri, R., Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell 21 (2012), 66–81.
6. 6 Nakamura, K., Taguchi, E., Miura, T., Yamamoto, A., Takahashi, K., Bichat, F., Guilbaud, N., Hasegawa, K., Kubo, K., Fujiwara, Y., Suzuki, R., Kubo, K., Shibuya, M., Isae, T., KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties. Cancer Res 66 (2006), 9134–9142.
7. 7 Kang, S., Roh, Y.J., Kim, I.B., Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice. Exp Eye Res 112 (2013), 125–133.
8. 8 Poor, S.H., Qiu, Y., Fassbender, E.S., Shen, S., Woolfenden, A., Delpero, A., Kim, Y., Buchanan, N., Gebuhr, T.C., Hanks, S.M., Meredith, E.L., Jaffee, B.D., Dryja, T.P., Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation. Invest Ophthalmol Vis Sci 55 (2014), 6525–6534.
9. 9 Marneros, A.G., NLRP3 inflammasome blockade inhibits VEGF-A-induced age-related macular degeneration. Cell Rep 4 (2013), 945–958.
10. 10 Campa, C., Kasman, I., Ye, W., Lee, W.P., Fuh, G., Ferrara, N., Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes. Invest Ophthalmol Vis Sci 49 (2008), 1178–1183.
11. 11 Green, L.S., Jellinek, D., Jenison, R., Ostman, A., Heldin, C.H., Janjic, N., Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry 35 (1996), 14413–14424.
12. 12 Patel, S., Combination therapy for age-related macular degeneration. Retina 29 (2009), S45–S48.
13. 13 Dong, A., Seidel, C., Snell, D., Ekawardhani, S., Ahlskog, J.K., Baumann, M., Shen, J., Iwase, T., Tian, J., Stevens, R., Hackett, S.F., Stumpp, M.T., Campochiaro, P.A., Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A. Angiogenesis 17 (2014), 553–562.
14. 14 Jo, N., Mailhos, C., Ju, M., Cheung, E., Bradley, J., Nishijima, K., Robinson, G.S., Adamis, A.P., Shima, D.T., Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol 168 (2006), 2036–2053.
15. 15 Jaffe, G.J., Eliott, D., Wells, J.A., Prenner, J.L., Papp, A., Patel, S., A phase 1 study of intravitreous E10030 in combination with ranibizumab in neovascular age-related macular degeneration. Ophthalmology 123 (2016), 78–85.